Name: Stejskal Vera, Dagmar, Mila Place of Birth: Prague Citizenship: Swedish Education And Academic Degrees: Biology- and chemistry studies at the Charles University in Prague 1961-1966 Scientific degrees RNDr (PhD) 1967 Associate professor of Immunology at the University of Stockholm 1976 Employment: Research Scientist, The Institute of Experimental Biology and Genetics in Prague, Czech republic 1967-1968 Research Scientist, Dept. of Immunology, The University of Stockholm, Sweden 1969-1977 Senior Research Adviser and 1977-2000 Head of Immunotoxicology Group at AB ASTRA, Safety Assessment, Södertälje, Sweden. Affiliation with the Dept of Clinical 1996- Chemistry, Danderyds Hospital and Karolinska Institute, Stockholm Sweden, research in Clinical Immunotoxicology Memberships: Swedish Society of Toxicology Scandinavian Society for Immunology Swedish Society of Allergology European Academy of Allergology and Clinical Immunology Swedish Society of Inventors Swedish Society of Physicians (fellow) Other Achievements: Responsible scientist in the field of Immunotoxicology at the Swedish Society of Toxicology (key person) Saved world no 1 bestselling drug Prilosec ® for Astra by setting up a study explaining the mechanisms of drug side-effects in one month toxicology study. Necrotizing vasculitis observed in drug -dosed animals was due to round worms and deworming of animals. Only genetically-related dogs from one family were affected. Upon the repeating the study with parasite-naive animals, no side-effects developed. MELISA®-like test was used for the demonstration of immunological memory to worm antigens in conventional but not in parasite-free animals. Owner of MELISA® trademark and of MELISA® patent in all major European countries Founder of MELISA® MEDICA foundation(1992) Recipient of the EEC grant on Biotech program "In vitro Immunotoxicology" List Of Publications: 1. Valentova V, Cerny J, Ivanyi J: The characterisation of the immunological memory of the IgM type of response in chickens. Folia Biol (Prague) 1966; 12:207 2. Ivanyi J, Valentova V, Cerny J: The dose of antigen required for suppression of the IgM and IgG antibody response in chickens. I. The kinetics and characterisation of serum antibodies. Folia Biol (Prag) 1966; 12:157 3. Ivanyi J, Valentova V: The immunological significance of taxonomic origin of protein antigen in chickens.Folia Biol (Prag) 1966; 12:36 4. Cerny J, Ivanyi J, Valentova V: Differences in antigen dose requirements for inhibition of the IgM and IgG antibody response in chicks. Kinetics of specific cellular response. Folia Biol (Prague) 1966; p.12 5. Valentova V, Cerny J, Ivanyi J: Immunological memory of IgM and IgG type antibodies. I. Requirements of antigen dose for induction and of time for development of memory. Folia Biol (Prag) 1967; 13:100 6. Stejskalova V, Ivanyi J, Kara J: Enhancement of antibody synthesis in vitro by -azauridine, uridine and actinomycin D. Folia Biol (Prag) 1970; 16:250 7. Perlmann P, Perlmann H, Biberfeld P, Stejskal V: Cytotoxicity of activated lymphocytes, mechanisms of activation and target cell lysis.VIth International Symposium of Immunopathology Grindelwald 1970 8. Stejskal V, Perlmann H, Perlmann P: Cytotoxicity in vitro of lymphocytes precultivated with antibody-treated target cells Acta Path Microbiol Scand Section B 1972; 80:174 9. Stejskal V, Holm G, Perlmann P: Differential cytotoxicity of stimulated lymphocytes against allogeneic and xenogeneic target cells (Abstract).Scand J Immunology 1972; 1:421 10. Stejskal V, Holm G, Perlmann P: Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and by staphylococcus filtrate. Cellul Immunol 1973; 8:71 11. Stejskal V, Lindberg S, Holm G, Perlmann P: Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. II. Activation by phytohemagglutinin. Cellul Immunol 1973; 8:82 12. Holm G, Stejskal V, Perlmann P: Cytotoxic effects of activated lymphocytes and their supernatants. Clin Exptl Immunol 1973;14:169 13. Stejskal V, Härfast B, Holm G, Perlmann P: MLC - and mitogen-induced cytotoxicity of human lymphocytes. Specificity and nature of effector cells 4th Meeting of Scand Soc for Immunology, Gothenburg, Sweden 1973; May 10-12th 14. Stejskal V, Holm G, Perlmann P: Lymphocyte activation by PWM or PHA Scand J Immunology 1973; 2:91 15. Stejskal V, Härfast B, Holm G, Perlmann P: Cytotoxicity of human lymphocytes induced by pokeweed mitogen or in mixed. lymphocyte culture. Eur J Immunol 1974; 4:126 16. Stejskal V, Härfast B, Holm G, Perlmann P: Cytotoxicity of human lymphocytes induced by PWM or by PHA. Differences in cytotoxic efficiency and cellular requirements.Proceedings of 8th Leucocyte Conference "Lymphocyte recognition and effector mechanisms" 1974 p.371 17. O'Toole C, Stejskal V, Perlmann P, Karlsson M: Lymphoid cells mediating tumor specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J Exptl Med 1974; 139:457 18. Perlmann P, Holm G, Stejskal V: Cell-mediated cytotoxicity in vitro. Target cell recognition and effector cell requirements. Transplant Proc 1973; p.4 19. Andersson T, Stejskal V, Härfast B: An in vitro method for study of human lymphocyte cytotoxicity against virus-infected target cells. J Immunol 1975; 114:237 20. Stejskal V: Species specificity of lymphocyte-target cell interaction in vitro. 6th Meeting of the Scand Soc for Immunology Bergen 1975; May 14-16th. Scand J Immunol 1975; 4:765 21. Stejskal V, Perlmann P: Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. III. Species-specificity of lymphocyte-target cell recognition in vitro. Europ J Immunol 1976; 6:347- 352 22. Stejskal V: Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. IV. Competitive inhibition of target cell lysis by addition of unlabeled cells. Scand J Immunol 1976; 5:479 23. Stejskal V: Species-specific lymphocyte-target cell interaction in vitro. In: Leukocyte membrane determinants regulating immune reactivity. Proceedings of 10th Leucocyte Culture Conference. Academic Press Inc 1976; p.659 24. Stejskal V: Study on lymphocyte-mediated allogeneic and xenogeneic cell recognition in vitro. Nordic Symposium on Immunological Maturation Turku 1975 27-28 November Scand J Immunol 1976; 5:451 25. Stejskal V, Pape GR, Perlmann P: The role of Fc-bearing cells and antibody in mitogen-induced lymphocyte-mediated cytotoxicity in vitro. 3rd European Immunology Meeting Copenhagen 1976; August 25-27th 26. Stejskal V: In vitro tests for evaluation of transfer factor (review). Proceedings of the Kabi symposium about transfer factor and multiple sclerosis Stockholm 1976;March 19th 27. Härfast B, Andersson T, Stejskal V, Perlmann P: Interactions between human lymphocytes and paramyxovirus-infected cells. Adsorption and cytotoxicity. J Immunology 1977;118:1132 28. Stejskal V, Pape GR, Perlmann P: Mechanism of target cell killing by activated lymphocytes in vitro. Proceedings of 11th Leucocyte Culture Conference Double Tree Inn Tucson Arizona USA 1977 29. Stejskal V: The effect of persistent worm colonization on immunological status of beagle dogs. Host-parasite interactions Umeâ Sweden 1979; June 6-8th 30. Zeromski J, Stejskal V:Assessment of dog lymphocyte surface markers. 14th Leucocyte Culture Conference Heidelberg Germany 1981; June 7-12 th 31. Stejskal V, Havu N, Malmfors T: Necrotizing Vasculitis as an Immunological Complication in Toxicity Study.Arch Toxicol Suppl; 1982; 5:283-286 32. Stejskal VDM, Olin R: The revival of the lymphocyte transformation test for diagnosis of drug-induced occupational allergy. XIth International congress of allergology and clinical immunology London 1982; October 17-22 th 33. Stejskal VM, Johansson I-G: Immunological aspects of toxocara canis infection in beagle dogs. Proceedings of the 11th Scandinavian Symposium of parasitology Hasseludden Sweden 1983; August 17-19th 34. Stejskal V, Forsbeck M, Olin R: Analysis of occupational contact eczema with epicutaneous test and with lymphocyte transformation test (LTT). The Swedish Medical Society Annual Congress Stockholm 1983; November 30th -December 2nd 35. Stejskal VDM, Olin R, Forsbeck M: Diagnosis of drug-induced occupational allergy by lymphocyte transformation test. In: Hayes AW, Schnell RC & Miya TS, eds. Developments in the Science and Practice of Toxicology 1983; p.559-562 36. Stejskal V, Slanina P, Olin R, Michaelsson G, Pring B: The use of the hapten-specific human lymphocyte transformation test at an immunotoxicological laboratory. ICI III Third International congress on toxicology San Diego USA 1983; August 28th- September 3 rd 37. Stejskal V, Olin R: The detection of human drug specific memory cells by lymphocyte transformation test in vitro. ICI - III Third International Congress on Toxicology San Diego USA 28 August-3 September 1983 38. Stejskal VDM: Immunotoxicology - Present situation and possible developments in the future. The Annual Pharmaceutical Congress in Stockholm 1984; October 8-10th 39. Slanina P, Bernhardsson Â, Machado L, Olin R, Stâlenheim G, Stejskal V: Psyllium-induced lymphocyte transformation in psyllium (Ispaghula) allergic patients. Allergy Clin Immunol 1984; p. 73 40. Zeromski J, Thorén-Tolling K, Bergqvist R, Stejskal V:DNA binding proteins in canine sera. A Method for removal of nonspecific DNA binding in the Farr assay.Vet Immunol Immunopathol 1984; 7:169-183 41. Stejskal VM, Kristofferson A, Olin R: Side-chain specific and penicilloyl-specific memory cells in penicillin-allergic workers and in non-allergic controls. Annual Meeting of the European Academy of Allergology 1985; June 2-5th 42. Stejskal VDM, Olin R, Forsbeck M: The use of lymphocyte transformation test for diagnosis of drug-induced occupational allergy.J Allergy and Clin Immunol 1986; 77:411-426 43. Stejskal VDM, Olin RG: The lymphocyte transformation test for diagnosis of drug-induced occupational allergy.16th Symposium of the Collegium Internationale Allergologicum Gothenburg 1986; August 17-21st 44. Stejskal VDM, Forsbeck M, Olin R: Side chain-specific lymphocyte responses in workers with occupational allergy induced by penicillins. Int Arch Allergy Appl Immunology 1987; 82:461-464 45. Stejskal VDM, Slanina P, Olin R, Machado L, Stâlenheim G, Forsbeck M: Occupational hypersensitivity to psyllium - allergic or pseudoallergic. Allergy Immunol (Life Sci Adv) 1990; 9:77-84 46. Stejskal VDM: Allergy to drugs and other chemicals diagnosed by the presence of specific memory cells in human blood. In: Ivanyi P, ed. Realm of tolerance. Springer Verlag, New York, London, Tokyo, 1989; 213-225 47. Björnström M, Thorman R, Stejskal V, Ehrnholm P, Pegelöw KO: Investigation of hypersensitivity to dental lidocaine using lymphocyte transformation test (LTT). Annual Congress of Odontology, Stockholm, Sweden 1990 November 22-24th 48. Stejskal VDM, Nilsson R, Grepe A: Immunological basis of adverse reactions to ionic radiographic contrast media. Acta Radiol 1990; 31:1-8 49. Cederbrant K, Stejskal V, Forsbeck M, Freyman H: The lymphocyte transformation t est (LTT) used as a routine test for diagnosis of drug allergy. 1st Nordic Conference of Toxicology and 8th Annual Meeting of Nord EMS, Beito, Norway 1990; May 21-25th 50. Stejskal V, Cederbrant K, Forsbeck M, Freyman H: Immunotoxicity of drugs and other chemicals studied by lymphocyte transformation test (LTT) in man. 1st Nordic Conference of Toxicology and 8th Annual Meeting of NordEMS, Beito, Norway 1990; May 21-25th 51. Stejskal VDM: Lymphocyte transformation test for diagnosis of isothiazolinone allergy in man. 9th International Symposium on Contact Dermatitis, Stockholm, Sweden 1990; May 17-19th 52. Stejskal V: Human Memory Lymphocytes may be used in Screening for Allergenic Epitopes of Low Molecular Haptens. XXIst Meeting of the Scandinavian Society for Immunology and VIth Summer School: Regulation of the Immune Response, Stockholm, Sweden 1990; June 11-14th 53. Cederbrant K, Stejskal V, Freyman H, Forsbeck M: The Lymphocyte Transformation test (LTT) for Diagnosis of Penicillin Allergy in Occupationally and Therapeutically Exposed Subjects. XXIst Meeting of the Scandinavian Society for Immunology and VIth Summer School: Regulation of the Immune Response, Stockholm, Sweden 1990 June 11-14th 54. Stejskal VDM, Forsbeck M, Nilsson R: Lymphocyte transformation test for Diagnosis of isothiazolinone allergy mMan. J Invest Dermatol 1990; 94:798-802 55. Forsbeck M, Stejskal VDM: Immunological and allergological evaluation of patients with changes in oral mucosa adjacent to amalgam fillings. Annual Congress of Odontology, älvsjö, Sweden 1990; November 28-30th 56. Stejskal V: Allergiska och immunologiska reaktioner mot dental material Seminar held by Karolinska Institute and Elementis Vitae Huddinge Hospital, Huddinge, Sweden 1992; April 6-7th 57. Stejskal V: Clinical immunotoxicology: The use of blood lymphocytes for detection of immune dysfunctions. First International Symposium on Functional Medicine, Maui, Hawaii, 1993;April 6-11th 58. Cederbrant K, Johansson U, Hultman P, Stejskal V: Adaption of the human memory lymphocyte immuno-stimulation assay (MELISA®) to the mouse system. Toxicogy and in vitro possibilites. Fourth CFN Symposium, Stockholm, 1993; September 19-21nd 59. Cederbrant K, Broman P, Kristoffersson A, Lindkvist A, Stejskal V, Sundell K: Different epitopes of the penicillin molecule determine the immunogenic and allergenic properties of penicillins in man. Proceedings of Medical Congress, Stockholm, 1993; p.60,December 1-3rd 60. Stejskal V, Cederbrant K, Forsbeck M, Marcusson J: Positive skin test towards gold can be verified with specific lymphocyte reactivity in vitro. Medical Congress, Stockholm, 1993; December 1-3 rd 61. Danersund A, Lindvall A, Stejskal V: Deviant immunological reactions to metals in patients with chronic fatigue syndrome. Medical Congress, Stockholm, 1993; December 1-3th 62. Berg E, Cederbrant K, Forsbeck M, Stejskal V: Adverse reactions towards dental materials-a medical concern? Medical Congress, Stockholm, 1-3 December, 1993 63. Frâst B, Scheele LV, Stejskal V: Adverse immunological reactions towards metals in patients with suspected "Amalgam symptom". Medical Congress, Stockholm, Sweden 1993, December 1-3rd 64. Stejskal V, Cederbrant K, Forsbeck M: Mercury-specific lymphocytes in patients with oral lichen: A tool for the study of systemic mercury sensitization. Medical Congress, Stockholm, 1993; December 1-3rd 65. Stejskal VDM, Cederbrant K, Lindvall A, Forsbeck M: MELISA® - an in vitro tool for the study of metal allergy. Toxicology in vitro 1994; 8:991-1000 66. Stejskal VDM: Immunological effects of amalgam components: MELISA® - a new test for the diagnosis of mercury allergy. International Symposium "Status Quo and Perspectives of Amalgam and Other Dental Materials", Europaeum, European Academy, Otzenhausen, Germany 1994; April 29th - May 1th 67. Stejskal VDM: Immunological reactions to metals in patients with Chronic Fatigue Syndrome. 2nd International Symposium on Functional Medicine, Ritz Carlton Hotel, Rancho Mirage, California, 1994; March 31th - April 2nd 68. Stejskal VDM: MELISA®, an in vitro tool for the study of metal allergy. The Seminar of American Academy of Biological Dentistry, Paradise Village Beach, Puerto Vallarta, Mexico 1994; November 18-20th 69. Berg A, Palmer B, Stejskal VDM: Immunological investigations in patients with silicone implants-a pilot study.Annual medical meeting in Stockholm1994; p. 70 November 30th -December 2nd 70. Tibbling L, Thuomas K-Â, Lenkei R, Stejskal V:Immunological and brain MRI changes in patients with suspected metal intoxication International Journal of Occupational Medicine and Toxicology 1995; 2:285-294. 71. Stejskal VDM: Immune respones to metals- impact on human health. Experimental, Therapeutic and Toxic manipulations of host defence systems, Hradec Králové, Czech Republic, 1995;June 12-15th 72. Stejskal VDM, Forsbeck M, Cederbrandt K, Asteman 0: Mercury-specific lymphocytes: an indication of mercury allergy in man. J Clin Immunol 1996; 16:31-40 73. Warbrick EV, Thomas AL, Stejskal,VDM, Coleman,JW: An analysis of b-lactam- derived antigens on spleen cell and serum proteins by MELISA® and Western blotting. Allergy 1995; 50:910-917 74. Stejskal VDM: MELISA®, an in vitro tool for the study of metal allergy (Abstract). Wissenschaftliche Tagung der Internationalen Gesellschaft für Präventivmedizin Prag, Karolinum 1995; April 28th - May 1th 75. Stejskal VDM, Marcusson-Stâhl M: Human lymphocyte responses induced by penicillins and metals in vitro: cytokine profiles in allergy and autoimmunity. BI0TECH meeting "In vitro Immunotoxicology" Athens 1996; Mars 14-17th 76. Stejskal VDM: Immunological aspects of metal hypersensitivity, studied with in vitro test - MELISA®: 1st meeting of International MELISA® Study Group: New Diagnostics and treatment of patients with dental metal intolerance. Bad Ennstal, Austria 1996; p.77 March 24-27th 77. Stejskal VDM: Immunological aspects of metal hypersensitivity, studied in vitro test - MELISA®. Immuntoxikologie der Metalle, Yacht Hotel Chiemsee Prien am Chiemsee, München, Germany 1996; May 10-11th 78. Stejskal VDM: Immunological aspects of heavy metals hypersensitivity. 4th Symposium on Preventive Dentistry, Prague 1996; May 24-25th. 79. Stejskal VDM: Diagnose von Metallunverträglichkeit im MELISA® test).Neue Diagnostische Methode und Behandlung von Patienten mit Zahn-Metallunverträglichheit, 2nd meeting of International MELISA® Study Group, Salzburg, Austria. 1996; November 8-10th 80. Stejskal VDM: Human hapten - specific lymphocytes: biomarkers of allergy in man. Drug Information Journal 1997; 31:1379-1382 81. Stejskal VDM: MELISA® - a new test for study of systemic sensitization to mercury and other dental materials. American Academy Biological Dentistry: Treatment and diagnosis in dentistry and medicine, Carmel, CA 1997; March 7-9th 82. Stejskal VDM: The role of heavy metals in autoimmunity and chronic degenerative diseases, 3rd Seminar of International MELISA® Study Group, Zurs am Arlberg, Austria 1997;April 10-13th 83. Stejskal VDM: Immunological effects of dental metal alloys: MELISA® - a new test for the diagnosis of mercury allergy. International Conference on human health effects of mercury exposure, Faroe Islands 1997; June 22-26nd 84. Stejskal VDM: Diagnosis of metal sensitivity by MELISA® and case reports.4th International MELISA® Study Group, Sjövillan, Danderyd, Sweden 1997; July 24-27th 85. Stejskal VDM: Chronic diseases caused by dental materials: The MELISA® test XII. Internationales Symposium für Umweltmedizin, September 5-7, 1997, Kassel- Wilhelmshöhe, BRD. 86. Stejskal VDM: Individual diagnostics of metal-sensitivity: 10 years experience with MELISA® 5th International MELISA® Study Group, , Klinik Bergkristall, Oberstaufen-Steibis, BRD 1998;April 3-5th 87. Stejskal VDM, Danersund A., Lindvall A, Hudecek R., Yaqob, A. Lindh, U. Mayer W. Bieger W: Metal-specific lymphocytes-biomarkers of sensitivity in man.Anual Meeting of Scandinavian Society for Immunology, Copenhagen, 1998; September 10-14th 88. Stejskal VDM: Diagnosis of individual immunologic metallic sensitivity. MELISA®-test, cases and biological demonstration.Cannes International Dental Congress, Cannes, France 1998; May 28-30th 89. Stejskal VDM: Individual objective diagnosis of metal sensitivity (MELISA®). Dental materials and psychoneuroimmunology, 6th International MELISA® Study Group, Sjövillan, Danderyds Hospital 1998; August 14-16th 90. Stejskal VDM: MELISA® - Memory Lymphocyte Immuno Stimulation Assay. Herbstsymposium, Zahnärzlichen Intressenverband Österreichs, Kurhotel Bad Ischl, Bad Ischl, Austria 1998; October 15-18th 91. Stejskal VDM: Individual diagnostics of metal sensitivity: 10 years of experience with MELISA®. 2nd Deutschsprachiger Kongress für Practische Umweltmedizin, Hamburg, BRD 1998; october 16-18th 92. Stejskal VDM: The memory lymphocyte immuno-stimulation assay - MELISA® - a new technology for diagnosis and monitoring of metal sensitivity. 33rd Annual Meeting of the American Academy of Environment Medicine, Baltimore, USA 1998; November 5-8th 93. Stejskal VDM., Hudecek R., Nordman V: Immunological considerations of risks connected with metallic restorations and general principles of metal replacement. Part 1, Dental Product Guide 1998, p. 34-36 94. Stejskal VDM., Hudecek R., Nordman V: Immunological considerations of risks connected with metallic restorations and general principles of metal replacement. Part 2, Dental Product Guide 1998, p.54-56. 95. Stejskal Vera: Immunologiska effekter av metallegeringar - vilka drabbas? IAOMT:s Utbildningskonferens, Tranâs, Sverige, 1998;September 4-6th 96. Cederbrant K.,Stejskal V.,Broman P.,Lindkvist L.,Sundell K: In vitro lymphocyte proliferation in the diagnosis of allergy to phenoxymethylpenicillin. Allergy 1998, 53:1155-1161 97. Stejskal VDM., Nordman V., Danersund A., Lindvall A., Hudecek R., Yaqob A., Lindh U., Mayer W., Bieger W: MELISA®, a tool for detection of metal allergy. International Scientific Conference " Dental Amalgam and heavy metals:are our health and environment at risk? European Parliament, Hemicycle Schuman, Luxembourg1999; January 7-8th 98. Stejskal V: Hypersensitivity against dental metals:diagnostics and monitoring by optimized lymphocyte transformation test-MELISA®. 13. Internationales Symposium fur Umweltmedizin, Hotel el Fuerte, Conil, Spanien 1999; Februar 26 - 28th 99. Stejskal V: Psychoneuroimmunologie und dentale Schwermetalle.5th Europäischen Kongresses fur Ganzheitliche Zahn-Medizin Hamburg,BRD 1999; April 15-18th 100. Stejskal VDM: Metal-specific lymphocytes : risk factors in allergy and autoimmunity.Nordic Symposium on Trace in Human Health and Disease. Helsinki, Finland 1999; June 16-19th 101. Stejskal V: Detection of metal allergy in psychosomatic disorders. Symposium,Psychosomatic disorders:is there a metal-dental connection? 7 th International MELISA® Study Group. Antwerpen,Belgium 1999; May 20th 102. Berg Einar., Stejskal Vera: Deviant reaction towards dental material-a medicine problem? Dental Product Guide 1999; 2:38-41. 103. Sterzl I, Hrda P., Prochazkova J., Bartova J., Matucha P.,Stejskal VDM: Response to metals in patients with chronic fatigue and autoimmune endocrinopathies. Neuroendocrinology Letters 1999; 20 :221-228 104. Stejskal VDM.,Dandersund A.,Lindvall A.,Hudecek R.,Nordman V.,Yaqob A Mayer W.,Bieger W.,Lindh Ulf: Metal-specific memory lymphocytes:biomarkers of sensitivity in man. Neuroendocrinology Letters 1999;20:289-298 105. Regland B.,Stejskal V.,Jahreskog M.,Nordman V.,Zachrisson OCH: Nickel allergy in patients with fibromyalgia and chronic fatigue syndrome. Second World Congress of Chronic Fatigue Syndrome and related disorders, Brussels, 1999; September 9-12th 106. Sterzl I.,Prochazkova J., Hrda P.,Bartova J.,Matucha P.,Stejskal V: Mercury and nickel Allergy: risk factors in fatigue and autoimmunity. Second World Congress on Chronic Fatigue Syndrome and related disorders, Brussels, 1999; September 9-12th 107. Stejskal V.,Danersund A., Lindvall A.,Hudecek R., Nordman V.,Yaqob A.,Mayer W Bieger W.,Lindh U: Metal-specific lymphocytes: risk factors in CFS and other related Diseases. Second World Congress on Chronic Fatigue and related disorders, Brussels, 1999; September 9-12 th 108. Stejskal J.,Stejskal V: The role of metals in autoimmunity and the link to neuroendocrinology. Neuroendocrinology Letters 1999;20:353-3 109. Stejskal V: Diagnostic des intolerance aux metaux: le test MELISA®. 1 er Colloque I.A.O.M.T."Biocompatibilite individuelle en medecine dentaire" Samedi 27 novembre 1999, Novotel, Paris-La Defense 110. Prochazkova J., Bartova J., Ivaskova E., Kupkova L., Sterzl I., Stejskal V: HLA-association with metal intolerancew to mercury and other metals in dental materials Disease Markers, 2000, 16:135-138 111. Regland B.,Stejskal V.,Jahreskog M, Zachrisson OCH, Gottfries, B: Nickel allergy in patients with fibromyalgia and chronic fatigue syndrome. J of Chronic Fatigue Syndrome, 2001, 8:57-63(?) 112 Stejskal VDM., Ringel ChP.,Vachon WB: Sensitivity to metals in dentistry: diagnostic approaches and monitoring by in vitro techniques. In press

|| Close ||